| 2022-05-23 | Sale | AbbVie Inc. ABBV | Vice Chairman | 11,605 0.0007% | $151.53 | $1.76M | +3.01% | |
| 2022-05-16 | Sale | AbbVie Inc. ABBV | Vice Chairman | 2,100 0.0001% | $155.27 | $326,067 | -1.89% | |
| 2022-05-06 | Sale | AbbVie Inc. ABBV | Vice Chairman | 47,215 0.0026% | $149.53 | $7.06M | -0.19% | |
| 2020-11-04 | Sale | AbbVie Inc. ABBV | Vice Chairman | 90,679 0.0054% | $93.61 | $8.49M | +19.05% | |
| 2018-08-17 | Sale | AbbVie Inc. ABBV | EVP, R&D and CSO | 100,000 0.0066% | $97.52 | $9.75M | -16.39% | |
| 2018-02-28 | Sale | AbbVie Inc. ABBV | EVP, R&D and CSO | 5,286 0.0003% | $117.93 | $623,367 | -18.36% | |
| 2017-11-10 | Sale | AbbVie Inc. ABBV | EVP, R&D and CSO | 51,266 0.0032% | $94.69 | $4.85M | +2.84% |